The findings of the study indicate that ovarian cancer patients with elevated expression of GPR137, NDEL1, and TUBA1A genes experienced a statistically significant increase in survival time, as demonstrated by Kaplan-Meier survival analysis (Figure 4D). Here, TUBA1A is linked to ovarian carcinoma.